$7.89
+0.17
(+2.15%)▲
0.11%
Downside
Day's Volatility :0.16%
Upside
0.05%
51.61%
Downside
52 Weeks Volatility :85.7%
Upside
70.45%
Period | Concord Medical Services Holdings Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -10.5% | 0.0% |
6 Months | 12.77% | 0.0% |
1 Year | -28.89% | 0.0% |
3 Years | -68.17% | -25.1% |
Market Capitalization | 32.8M |
Book Value | -$489.59 |
Earnings Per Share (EPS) | -12.16 |
PEG Ratio | 0.0 |
Wall Street Target Price | 1.2 |
Profit Margin | -80.33% |
Operating Margin TTM | -90.37% |
Return On Assets TTM | -4.4% |
Return On Equity TTM | -32.4% |
Revenue TTM | 471.7M |
Revenue Per Share TTM | 107.98 |
Quarterly Revenue Growth YOY | -23.1% |
Gross Profit TTM | -152.4M |
EBITDA | -330.1M |
Diluted Eps TTM | -12.16 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Downside of 84.79%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 27.7M | ↓ 42.32% |
Net Income | -34.1M | ↓ 17.39% |
Net Profit Margin | -123.04% | ↓ 37.14% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 28.3M | ↑ 3.91% |
Net Income | -50.2M | ↑ 49.91% |
Net Profit Margin | -177.5% | ↓ 54.46% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 34.1M | ↑ 12.43% |
Net Income | -61.8M | ↑ 14.75% |
Net Profit Margin | -181.17% | ↓ 3.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 76.3M | ↑ 117.76% |
Net Income | -128.9M | ↑ 103.11% |
Net Profit Margin | -168.98% | ↑ 12.19% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 67.7M | ↓ 2.79% |
Net Income | -70.2M | ↓ 40.33% |
Net Profit Margin | -103.72% | ↑ 65.26% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 75.3M | ↑ 13.84% |
Net Income | -41.7M | ↓ 39.21% |
Net Profit Margin | -55.39% | ↑ 48.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 20.6M | - |
Net Income | -6.6M | - |
Net Profit Margin | -31.98% | - |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.7M | ↓ 71.14% |
Net Income | -6.4M | ↑ 0.0% |
Net Profit Margin | -110.82% | ↓ 78.84% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 126.4M | ↑ 208.03% |
Net Income | -103.3M | ↑ 127.15% |
Net Profit Margin | -81.72% | ↑ 29.1% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 34.9M | ↓ 72.37% |
Net Income | -103.3M | ↑ 0.0% |
Net Profit Margin | -295.75% | ↓ 214.03% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 30.3M | ↓ 13.21% |
Net Income | -23.9M | ↓ 76.9% |
Net Profit Margin | -78.72% | ↑ 217.03% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 665.6M | ↑ 32.32% |
Total Liabilities | 335.5M | ↓ 5.67% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 612.7M | ↓ 6.28% |
Total Liabilities | 343.4M | ↑ 4.18% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 815.6M | ↑ 24.13% |
Total Liabilities | 448.5M | ↑ 21.82% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 978.3M | ↑ 16.79% |
Total Liabilities | 547.4M | ↑ 18.83% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 860.5M | ↓ 3.61% |
Total Liabilities | 571.7M | ↑ 14.43% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 847.8M | ↑ 0.82% |
Total Liabilities | 603.1M | ↑ 7.96% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 880.6M | ↑ 1.08% |
Total Liabilities | 577.7M | ↓ 0.18% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 847.4M | ↑ 0.0% |
Total Liabilities | 555.9M | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.1B | ↓ 0.27% |
Total Liabilities | 4.3B | ↑ 8.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 847.8M | ↑ 0.0% |
Total Liabilities | 603.1M | ↑ 0.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↑ 9.39% |
Total Liabilities | 4.7B | ↑ 9.17% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 6.6B | ↑ 0.0% |
Total Liabilities | 4.7B | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.6M | ↓ 244.36% |
Investing Cash Flow | -145.2M | ↑ 219.59% |
Financing Cash Flow | 174.6M | ↑ 518.83% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -27.9M | ↑ 406.2% |
Investing Cash Flow | -152.8M | ↑ 7.11% |
Financing Cash Flow | 73.2M | ↓ 57.34% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -35.1M | ↑ 17.62% |
Investing Cash Flow | -81.6M | ↓ 50.17% |
Financing Cash Flow | 174.0M | ↑ 121.78% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -56.4M | ↑ 56.38% |
Investing Cash Flow | -88.9M | ↑ 6.01% |
Financing Cash Flow | 100.9M | ↓ 43.56% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -31.1M | ↓ 39.69% |
Investing Cash Flow | -17.0M | ↓ 79.01% |
Financing Cash Flow | 54.9M | ↓ 40.37% |
Q2 FY19 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 0.0 | ↓ 100.0% |
Investing Cash Flow | 0.0 | - |
Financing Cash Flow | 0.0 | ↓ 100.0% |
Sell
Neutral
Buy
Concord Medical Services Holdings Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Concord Medical Services Holdings Ltd | 14.24% | 12.77% | -28.89% | -68.17% | -72.11% |
Fresenius Medical Care Ag | -6.53% | -8.77% | 14.55% | -42.05% | -46.64% |
Hca Holdings, Inc. | -11.55% | 15.66% | 56.72% | 43.77% | 162.22% |
Tenet Healthcare Corp. | -3.51% | 31.27% | 189.34% | 124.2% | 475.7% |
Universal Health Services Inc. | -8.37% | 20.82% | 62.76% | 66.97% | 47.11% |
Davita Healthcare Partners Inc. | -11.01% | -0.46% | 81.97% | 36.07% | 130.3% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Concord Medical Services Holdings Ltd | NA | NA | 0.0 | 0.0 | -0.32 | -0.04 | NA | -489.59 |
Fresenius Medical Care Ag | 19.94 | 19.94 | 0.4 | 2.51 | 0.05 | 0.03 | 0.03 | 47.48 |
Hca Holdings, Inc. | 16.05 | 16.05 | 1.16 | 22.23 | 0.12 | 0.12 | 0.01 | -8.39 |
Tenet Healthcare Corp. | 4.94 | 4.94 | 0.81 | 10.57 | 0.6 | 0.07 | NA | 40.32 |
Universal Health Services Inc. | 13.66 | 13.66 | 1.87 | 15.93 | 0.16 | 0.07 | 0.0 | 99.28 |
Davita Healthcare Partners Inc. | 15.07 | 15.07 | 1.05 | 9.72 | 0.45 | 0.07 | NA | 4.68 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Concord Medical Services Holdings Ltd | Sell | $32.8M | -72.11% | NA | -80.33% |
Fresenius Medical Care Ag | Hold | $11.5B | -46.64% | 19.94 | 2.73% |
Hca Holdings, Inc. | Buy | $90.5B | 162.22% | 16.05 | 8.52% |
Tenet Healthcare Corp. | Buy | $14.8B | 475.7% | 4.94 | 14.91% |
Universal Health Services Inc. | Hold | $13.7B | 47.11% | 13.66 | 6.66% |
Davita Healthcare Partners Inc. | Hold | $11.6B | 130.3% | 15.07 | 6.53% |
Insights on Concord Medical Services Holdings Ltd
Revenue is down for the last 3 quarters, 126.44M → 30.32M (in $), with an average decrease of 42.8% per quarter
Netprofit is up for the last 2 quarters, -103.33M → -23.87M (in $), with an average increase of 332.9% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 189.3% return, outperforming this stock by 218.2%
In the last 3 years, Tenet Healthcare Corp. has given 124.2% return, outperforming this stock by 192.4%
Renaissance Technologies Corp
Rhumbline Advisers
concord medical services holdings limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the people's republic of china. the company operates in network and hospital segments. the company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. it also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. in addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical resear
Organization | Concord Medical Services Holdings Ltd |
Employees | 727 |
CEO | Dr. Jianyu Yang |
Industry | Health Services |
Victoryshares International
$7.89
+2.15%
Clearbridge Focus Value Esg Etf
$7.89
+2.15%
Cabana Target Drawdwn 10 Etf
$7.89
+2.15%
Spdr Nyse Technology Etf
$7.89
+2.15%
Global Ship Lease Inc-cl A
$7.89
+2.15%
Standard Motor Products Inc
$7.89
+2.15%
Cp High Yield Trend Etf
$7.89
+2.15%
Gain Therapeutics Inc
$7.89
+2.15%
Olaplex Holdings, Inc.
$7.89
+2.15%